Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Exkivity provides a new treatment option for NSCLC patients with EGFR exon 20 in···【more】
Release date：2024-08-07Recommended：160
Capmatinib inhibits the proliferation and survival of MET-dependent cancer cells···【more】
Release date：2024-08-07Recommended：135
Exkivity is an innovative, oral, small molecule tyrosine kinase inhibitor (TKI) ···【more】
Release date：2024-08-07Recommended：154
Capmatinib is highly selective for c-Met targets, can effectively inhibit the pr···【more】
Release date：2024-08-07Recommended：167
Capmatinib prevents the growth and spread of cancer cells by inhibiting MET tyro···【more】
Release date：2024-08-06Recommended：208
Capmatinib is a targeted therapy for patients with non-small cell lung cancer wi···【more】
Release date：2024-08-06Recommended：231
Capmatinib is an oral drug manufactured by Novartis Pharmaceutical. It is a tyro···【more】
Release date：2024-08-06Recommended：203
Capmatinib inhibits the growth of cancer cells caused by specific genetic varian···【more】
Release date：2024-08-06Recommended：213
The price of Exkivity varies depending on a number of factors, including the ver···【more】
Release date：2024-08-06Recommended：188
Exkivity is an orally targeted drug targeting EGFR gene mutations for the treatm···【more】
Release date：2024-08-06Recommended：207
Exkivity is a targeted therapy for specific types of non-small cell lung cancer ···【more】
Release date：2024-08-06Recommended：198
Exkivity is a targeted drug for the treatment of specific types of lung cancer, ···【more】
Release date：2024-08-06Recommended：261
